Status:

NOT_YET_RECRUITING

Short- to Medium-term Outcome of Minimally Invasive Carpal Tunnel Release

Lead Sponsor:

University Hospital, Basel, Switzerland

Conditions:

Carpal Tunnel

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The aim of the study is to determine whether minimally invasive, ultrasound-guided thread carpal tunnel release leads to faster functional recovery compared to standard open and endoscopic techniques ...

Detailed Description

Carpal tunnel syndrome (CTS) is the most common peripheral nerve compression disorder encountered in hand surgery. It affects a broad demographic, from young women (often linked to pregnancy and breas...

Eligibility Criteria

Inclusion

  • Patient aged 18 years or older
  • Electroneurographically proven carpal tunnel syndrome
  • Informed Consent for trial participation

Exclusion

  • Revision surgery
  • Inability to give informed consent, whether it be due to an insurmountable language barrier or another reason

Key Trial Info

Start Date :

May 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

61 Patients enrolled

Trial Details

Trial ID

NCT06997172

Start Date

May 1 2025

End Date

September 1 2026

Last Update

May 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Basel

Basel, Switzerland, 4031

Short- to Medium-term Outcome of Minimally Invasive Carpal Tunnel Release | DecenTrialz